Bumper Offer - Urjas oil Just @ Rs. 1
Tsart 80 Tablet is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Heart Failure, High BP. Tsart 80 Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Tsart 80 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Common side effects of Tsart 80 Tablet include Dizziness, Nausea or vomiting, Back Pain. Besides the aforementioned side effects, there are other adverse effects of Tsart 80 Tablet as well, which are listed below. These side effects of Tsart 80 Tablet are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Tsart 80 Tablet has a Severe effect for pregnant women and Mild effect on lactating mothers. In addition, Tsart 80 Tablet's effects on the liver, heart and kidney are discussed below in the Tsart 80 Tablet related warnings section.
Tsart 80 Tablet is contraindicated in people with pre-existing medical conditions like Angioedema, Hyperkalemia, Drug Allergy as it can result in adverse effects.
Besides this, Tsart 80 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Tsart 80 Tablet is not safe while driving, and is not addiction.
Tsart 80 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Tsart 80 Tablet is used -
Severe
Mild
Common
Is the use of Tsart 80 Tablet safe for pregnant women?
Tsart should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Tsart 80 Tablet safe during breastfeeding?
Tsart has been seen to have minimal side effects on breastfeeding women.
What is the effect of Tsart 80 Tablet on the Kidneys?
Tsart is not harmful for kidneys.
What is the effect of Tsart 80 Tablet on the Liver?
Tsart is rarely harmful for the liver.
What is the effect of Tsart 80 Tablet on the Heart?
Side effects of Tsart rarely affect the heart.
Tsart 80 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Tsart 80 Tablet unless your doctor advises you to do so -
Is this Tsart 80 Tablet habit forming or addictive?
Forming a habit of Tsart 80 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Tsart 80 Tablet, you should not drive or work on any heavy machine, as Tsart 80 Tablet can make you drowsy.
Is it safe?
Tsart 80 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Tsart 80 Tablet in mental disorders is not effective.
Interaction between Food and Tsart 80 Tablet
When consumed with certain foods, Tsart 80 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Tsart 80 Tablet
Taking alcohol with Tsart 80 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
